AzTrials
AzTrials

DrowningCPAPDROWNINGNCT06183827

Drowning-related Acute Respiratory Failure

A study testing Emergency Medical Service intervention : Oxygen Supply strategy and Emergency Medical Service intervention : Continuous Positive Airway Pressure strategy in people with Drowning, run by Assistance Publique Hopitaux De Marseille at 9 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to assess the Non-Invasive Ventilation-Continuous Positive Airway Pressure efficacy (experimental group) for drowning related Acute Respiratory Failure compared to Oxygen Supply by face mask (15Liters/minutes) (control group). Read more about this study

Who is it for?
Ages 1 year and older
Conditions the study is for
Drowning
What is being tested?
Emergency Medical Service intervention : Oxygen Supply strategy and Emergency Medical Service intervention : Continuous Positive Airway Pressure strategy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
210 participants
Where
9 sitesFrance
Study dates
24 Jul 2024to Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Man/boy or woman/girl, 1yo and older.
  • Subject suffering from drowning related-Acute Respiratory Failure (whatever the nature of water, salt or fresh) and benefiting from the Emergency Medical Service intervention;
  • Acute Respiratory Failure defined as the presence of:
  • Capillary O2 saturation <92% upon Emergency Medical Service first clinical analysis at the drowning scene;
  • Need for oxygen supply 15Liters/minutes to reach capillary O2 saturation ≥ 95%;
  • Combination of Acute Respiratory Failure clinical signs: at least 1 of the following items: respiratory rate >30/min, sternal or clavicular indrawing, abdominal breathing, cyanosis.
Show all 9Show fewer
  • Individual affiliated to or beneficiary of a French health insurance system;
  • Individual with the ability to benefit from the two strategies (ambivalence clause);
  • Adult Individual having signed written informed consent or child subject with an authorization of the parents.

Who cannot join

  • Individual with hypothermia ≤ 34°C ;
  • Individual with neurological distress defined by a Glasgow Coma Scale < 13 at first clinical assessment and during the first 15 minutes of care ;
  • Individual with hemodynamic distress defined by a systolic blood tension < 90 mmHg at first clinical assessment and during the first 15 minutes of care ;
  • Cardiac arrest or respiratory arrest ;
  • Declared pregnancy or breastfeeding ;
  • Patient under legal protection regime for adults.

Trial locations and contacts

9 sites in 1 country. Contact the study team or a site near you to ask about taking part.

9 sites in 1 country

France9 sites, 9 recruiting
  • Centre Hospitalier de la Côte Basque - Urgences

    Bayonne

    LABES, MD

    Recruiting
  • Groupe Hospitalier PELLEGRIN - SAMU-SMUR

    Bordeaux

    Bruno SIMONNET, MD

    Recruiting
  • CH La Rochelle - Urgence

    La Rochelle

    Ombeline SUSONG, MD

    Recruiting
  • Centre Hospitalier Côte de Lumière - SAMU/SMUR 85

    Les Sables-d'Olonne

    Stanislas BAWEJSKI, MD

    Recruiting
  • CHU Timone - APHM

    Marseille, 13005

    Pierre Michelet, MD, 638741313 ext. +33, pierre.michelet@ap-hm.fr

    Not yet recruiting
  • CHU de Montpellier - Hôpital Lapeyronie

    Montpellier

    Mustapha SEBBANE, MD

    Recruiting
  • CHU de Nantes - Urgences/SAMU

    Nantes

    Emmanuel MONTASSIER, MD

    Recruiting
  • CHU Nice Hôpital Pasteur

    Nice

    Céline OCCELLI, MD

    Recruiting
  • CHITS Hôpital Ste Musse

    Toulon, 83053

    Muriel Vergne, MD

    Recruiting

Other trials in France

About this study

Official title: Evaluation of Non-Invasive Ventilation/Continuous Positive Airway Pressure for Drowning-related Acute Respiratory Failure

The purpose of this study is to assess the Non-Invasive Ventilation-Continuous Positive Airway Pressure efficacy (experimental group) for drowning related Acute Respiratory Failure compared to Oxygen Supply by face mask (15Liters/minutes) (control group).

Read the detailed description

Open-label, multicenter, prospective, cross-over cluster randomized (ratio 1:1), conducted in 16 Emergency Medical Service centers in France :

  • Experimental group: Non-Invasive Ventilation-Continuous Positive Airway Pressure (Arm 1)
  • Control group: Oxygen Supply by face mask (Arm 2)

Drowning-related acute respiratory failure has important clinical consequences (4 to 18% mortality). No national/international medical consensus exist for its management.

Our team has successively demonstrated that:

  • The acute respiratory failure related to drowning in salt or fresh water presented the same clinical pathway and prognosis ;
  • Most victims with drowning related acute respiratory failure do no present hemodynamic instability ;
  • If the oxygenation is rapidly improved, neurological status is also maintained in acute respiratory failure victims ;
  • Pediatric and adult presentations are similar.

Facing an acute respiratory failure, emergency medical service must rapidly choose between oxygen supply by face mask (15 liters /minutes), mechanical ventilation or non-invasive ventilation. mechanical ventilation as non-invasive ventilation present interests and side arms. No comparative study has been conducted between these strategies. The arguments for non-invasive ventilation use specifically in a continuous positive airway pressure mode are:

  • Fast recovery of acute respiratory failure in 24h
  • Retrospective publications showing that the benefit of non-invasive ventilation probably based on continuous positive airway pressure mode
  • Easy implementation of continuous positive airway pressure in the pre-hospital setting (adults, children, newborns)
  • Complexity of mechanical ventilation in pre-hospital setting. Our working hypothesis is the efficacy of early use of non-invasive ventilation-continuous positive airway pressure in drowning related acute respiratory failure.
Conditions
Drowning
Being tested
Emergency Medical Service intervention : Oxygen Supply strategy, Emergency Medical Service intervention : Continuous Positive Airway Pressure strategy
Medical subject headings
Drowning

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Emergency Medical Service intervention : Oxygen Supply strategyProcedure or surgery

    During the 4-month period of control, the care teams will:

    • Use Oxygen Supply by face mask (15Liters/minutes) from pre-hospital to intensive care unit admission until the 6th hour following the start of drowning care (Emergency Medical Service arrival at the scene).

    Indeed, current concepts of advanced prehospital care include the use of oxygen by face mask (15Liters/minutes) and intubation-Mechanical Ventilation in case of failure. The requirement of intubation-Mechanical Ventilation by the Emergency Medical Service (pre-hospital phase) or Intensive Care Unit (hospital phase) practitioners during this first 6 hours period will be left to the discretion of the practitioners in charge of the patient;

    • Continue this strategy in the Intensive Care Unit until the Acute Respiratory Failure resolution allows a reduction of Oxygen Supply. The Oxygen Supply will be reduced progressively litter by litter each 12 hours period with maintenance of capillary saturation up to 92%.
  • Emergency Medical Service intervention : Continuous Positive Airway Pressure strategyProcedure or surgery

    During the 4-month period of experimentation, the care teams will:

    • Use Non-Invasive Ventilation by Continuous Positive Airway Pressure (set between 8 to 10 cm H2O) from pre-hospital setting to Intensive Care Unit admission until the 6th hour following the start of drowning care (Emergency Medical Service arrival at the scene).

    The requirement of Mechanical Ventilation by the Emergency Medical Service (pre-hospital phase) or Intensive Care Unit (hospital phase) practitioners during this first 6 hours period will be left to the discretion of the practitioners in charge of the patient.

    • Continue this strategy in the Intensive Care Unit until the Acute Respiratory Failure resolution allows a reduction of Non-Invasive Ventilation-Continuous Positive Airway Pressure. Non-Invasive Ventilation-Continuous Positive Airway Pressure support will be weaned progressively (left at practitioners' convenience) with maintenance of capillary O2 saturation up to 92%.
Study groups in NCT06183827
Study groupRoleWhat they receive
the Oxygen Supply strategyActive comparatorNot described
Receives: Procedure: Emergency Medical Service intervention : Oxygen Supply strategy
the Continuous Positive Airway Pressure strategyExperimentalNot described
Receives: Procedure: Emergency Medical Service intervention : Continuous Positive Airway Pressure strategy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inability to improve oxygen saturation up than 92%

    Indication of intubation/mechanical ventilation requirement in the first 6 hours based on following criteria : Inability to improve oxygen saturation up than 92% despite the ventilatory strategy used;

    Measured: 6 hours

  2. Glasgow Coma Scale

    Indication of intubation/mechanical ventilation requirement in the first 6 hours based on following criteria : Glasgow Coma Scale < 13

    Measured: 6 hours

  3. Cardiac arrest occurrence

    Indication of intubation/mechanical ventilation requirement in the first 6 hours based on following criteria : Cardiac arrest occurrence

    Measured: 6 hours

  4. Systolic arterial pressure

    Indication of intubation/mechanical ventilation requirement in the first 6 hours based on following criteria : Systolic arterial pressure < 90 mmHg

    Measured: 6 hours

  5. Aspiration

    Indication of intubation/mechanical ventilation requirement in the first 6 hours based on following criteria : Aspiration

    Measured: 6 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2023
  2. Study start24 Jul 2024
  3. Primary completionMar 2027 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Multicenter, prospective, cross-over cluster randomized study
Masking
None (open label)
Enrolment
210 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06183827
Sponsor's protocol ID
2023-A01181-44
Acronym
CPAPDROWNING
Status last verified
Feb 2026
First submitted
5 Dec 2023
Last updated
6 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Emergency Medical Service intervention : Oxygen Supply strategy and Emergency Medical Service intervention : Continuous Positive Airway Pressure strategy in people with Drowning, run by Assistance Publique Hopitaux De Marseille at 9 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pierre Michelet, MD (638741313 ext. +33, pierre.michelet@ap-hm.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inability to improve oxygen saturation up than 92% (time frame: 6 hours). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in